Introduction
Since it was first reported in 1985 in Science, 1 phage display technology has played a key role towards the development of antigen-specific peptides. Specifically, bacteriophages are used to choose select peptides with high specificity and affinity towards a desired antigen from a pool consisting of a large number of potential peptides. Their subsequent use for the recognition of specific target molecules and biomarkers has yielded a variety of economical, rapid, and efficient applications in fields such as vaccine development, enzyme inhibition, inflammation, and cancer research. In particular, the readily available information on the genomic makeup of various bacteriophages has enabled researchers to easily engineer foreign entities (ie, proteins, peptides, and so on) on the extraluminal surface, which in turn has enabled their widespread use for phage display applications. While bacteriophages have continued to receive interest for these reasons, the last 10 years in particular have seen an emergence of novel bacteriophage-based biosensor applications in the form of nanotemplates or nanoprobes ( Figure 1 ).
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Lee et al (for example, deoxyribonucleic acid [DNA] or ribonucleic acid), and the latter binds to receptors on the surface of its host (for example, bacteria) to inject its genome for subsequent host infection, and ultimately, the replication and proliferation of bacteriophages. [4] [5] [6] [7] Provided that there is adequate culture of the host, an economical, rapid, and reproducible means to mass produce genetically-engineered bacteriophages is possible, 8 thereby providing an excellent alternative to conventional artificially-synthesized nanoconstructs (ie, nanoparticles, nanorods, and nanotubes). Additionally, their morphological variations (dimensions ranging from 40 nm to 2 µm with linear or polygonal capsid structures), the ease with which genetic modifications can be made to their structure and functionality, and their biocompatibility confer further advantages over traditional nanoconstructs. 9 In essence, bacteriophages have transcended their mere use in phage display technology to play an expanded role in the development of various applications such as biosensing, cellular imaging, vaccine development, and drug and gene delivery. [10] [11] [12] [13] [14] [15] Herein, we categorize bacteriophages by their morphology into M13-based filamentous phages and T4-or T7-based 
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Nanoscale bacteriophage biosensors icosahedral phages. We then examine recent technological trends, as well as bacteriophage development as biosensors, and discuss their prospective use in the field of biotechnology ( Figure 3 ).
Filamentous bacteriophages as biomedical nanoprobes
M13, a representative type of filamentous bacteriophage, resembles a long thread of string with its 6 nm thick and 1 µm long dimensions (Figure 2A ). Approximately 3,000 p8 subunits, a type of major coat protein, form a cylinder to encapsulate the M13 single-stranded DNA. Furthermore, each phage is capped by five p3 and p6 subunits on one end, and by five p7 and p9 subunits at the other end. [17] [18] [19] [20] [21] Among the sequences for the major and minor coat proteins, those for p3, p8, and p9 are particularly amenable for genetic modification for the consequent expression of recombinant coat protein subunits on the surface of the filamentous phage. Specifically, up to three different types of peptides can be expressed on the surface via corresponding modifications to the p3, p8, and p9 sequences. Such flexibility imparts multiple functions to the bacteriophage, and not surprisingly, has paved the way for the use of filamentous bacteriophage for a variety of multifunctional nanoprobes. [22] [23] [24] [25] [26] [27] [28] [29] The most common form of filamentous bacteriophagebased biosensor is engineered by conjugating targeting moieties and fluorescent molecules onto the capsid surface, ultimately for the detection of target analyte and for the transduction of signal via fluorescence. 30, 31 For example, Li et al 9 constructed a bacteriophage capable of targeting a HeLa contaminant KB cell line and emitting fluorescence upon target binding ( Figure 4A) Another common type of genetically-engineered filamentous bacteriophage-based sensor involves the conjugation of nanoparticles to the capsid, in which the unique properties of each type of nanoparticle is exploited in an application-specific manner. [33] [34] [35] In one instance, Lee et al 10 engineered a bacteriophage with a peptide library against a specific antigen on the p3 subunit and gold (Au) nanoparticles on its p8 subunit. By measuring the ultraviolet absorbance from the engineered bacteriophage, the authors demonstrated the capacity to detect protein down to 25 fmoles. In another example, Mao et al 36 expressed a peptide on the p8 subunits of E3 and M13 bacteriophages, capable of electrostatically binding to silver particles for antibacterial applications ( Figure 4B ). By fabricating a silver-coated phage for the selective killing of bacterial cells, the authors demonstrate 99% and 74% bacterial cell death via the use of E3 and M13 bacteriophages, respectively. 
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Nanoscale bacteriophage biosensors Another type of f ilamentous bacteriophage-based biosensor uses the piezoelectric effect of quartz crystal microbalance (QCM) sensors. Generally coated with a layer of metal such as Au, QCM sensors enable the real-time analysis of biomolecular interactions down to the nanogram scale. Conventional QCM methods, however, have disadvantages such as limited sensitivity due to the internal friction generated from the direct binding of analyte to the transducer. To overcome such issues, modified QCM biosensors have been developed based on the immobilization of bacteriophages onto the surface of QCM. For instance, Huang et al 37 expressed a peptide with an affinity for Salmonella typhimurium on the surface of E2 bacteriophages, and immobilize the modified bacteriophage onto a QCM sensor ( Figure 4C) . The authors demonstrated a detection limit of 102 cells mL -1 within an assay time of 3 minutes. Similarly, Olsen et al 38 Expressed the VTPPTQHQ peptide, specific for Salmonella typhimurium, onto the 7b1 filamentous phage, and immobilized the bacteriophage onto a QCM sensor for subsequent resonance measurements.
Traditional methods used for the detection of bacteria such as the enumeration of colonies in vitro, the use of polymerase chain reaction, or enzyme-linked immune sorbent assays, are generally time-consuming and require a large number of samples. The detection of pathogens in the field, however, requires the real-time detection of the target analyte in-situ. Accordingly, the use of bacteriophage-based magnetoelastic (ME) resonators is emerging.
39-41 ME resonators -composed of a material that lengthens and shortens under an external magnetic field -emit a characteristic resonance frequency upon exposure to the external magnetic field and release an oscillatory signal, which is ultimately detected via a pickup coil. Bacteriophage nanoprobes used in bacteriophagebased ME biosensors are genetically modified to bind to a target pathogen and are immobilized onto the resonator. Upon capture of the target pathogen, the ME biosensor is placed under increasing load, and the resulting decrease in resonance frequency is measured as a means to analyze the number of pathogens. 37, 42 For example, Li et al 42 immobilized E2 phage, genetically modified to express a peptide against S. typhimurium, onto the surface of ME resonators, and they used the modified ME biosensor to demonstrate the real-time ability to track in situ S. typhimurium levels on the surface of a tomato. The binding of the modified bacteriophage onto S. typhimurium is confirmed via scanning electron microscopy and a detection sensitivity of 50 colony-forming units/mL -1 is obtained. In another example, Shen et al 43 immobilized the JRB7 phage, modified to express a library against Bacillus anthracis spores onto a ME resonator, and used the system to take real-time measurements of in vitro biomarker concentrations from the solution. The use of fluorescent tags in biosensors is quite often a time-consuming process that alters the physical and chemical properties of the target analyte. To overcome such obstacles, optical sensors, such as the use of surface plasmon resonance (SPR), provide real-time measurements on biomolecular interactions without the need for fluorescent tags. SPR sensors, however, are relatively large in size, complicated in their structure, and require an external microfluidic channel, as well as an optical detection system. 44 Optofluidic ring resonators compensate for such weaknesses by combining microfluidic channels with microsized ring resonators to reduce the overall size of the sensor (,4 µm), thereby offering an alternative fluorescent label-free method for the real-time detection of the target analyte. 45 Zhu et al 46 engineered an OFRR biosensor that utilizes R5C2 filamentous phages -genetically modified to express biotin -as receptors for the detection of streptavidin, a protein tetramer with a high affinity for biotin ( Figure 4D ). By demonstrating a detection sensitivity down to 100 pM and a dissociation constant of 25 pM, the authors present a cheap and highly-sensitive platform for the detection of biomolecules.
Icosahedral bacteriophages as biomedical nanoprobes
While filamentous bacteriophages can be engineered to express peptides or proteins on their surface, their secretion and consequent interaction with the bacteria cell membrane needs to be taken into consideration. While such nonlytic filamentous bacteriophages secrete newly synthesized phages by merging with the host cellular membrane, icosahedral bacteriophages lyse the host cell following infection of the host and replication of the viral genome. Unlike nonlytic filamentous bacteriophages that secrete newly synthesized phages by merging with the host cellular membrane, icosahedral bacteriophages lyse the host cell following infection of the host and replication of the viral genome. 47 This lytic cycle of icosahedral bacteriophages ensures that the expression of foreign proteins or peptides on the capsid surface is not hindered by the need to consider their interaction with the bacterial cell membrane. In other words, without the need to consider the effect of such foreign constructs on bacteriophage uptake and its distribution from the host, researchers have a much wider spectrum of constructs to choose from when engineering a bacteriophage. [48] [49] [50] In addition, Krumpe 
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Lee et al mutation or sequence bias when expressing a peptide library on the capsid of T7 icosahedral bacteriophages than on that of M13 filamentous bacteriophages. Furthermore, icosahedral bacteriophages do not exhibit issues of aggregation, as observed with filamentous bacteriophages ( Figure 1A) , making them appropriate for use in applications that require monodispersed nanoprobes. Finally, icosahedral bacteriophages have complex structural symmetry denoted by their capsid (icosahedral symmetry) and tail fibers (helical symmetry). This inherent anisotropy is in contrast to traditional isotropic nanoconstructs (quantum dots, nanoparticles, nanotubes, liposomes, and so on), 52 making it possible to engineer a true Janus nanoconstruct (ie, a different peptide or protein displayed on the capsid from the tail fiber) with multiple functions incorporated into one construct. 53 Such icosahedral bacteriophage attributes will most likely generate growing interest among researchers to yield a variety of unique nanosensors in the future.
An examination of recent literature detailing the use of icosahedral bacteriophages as nanosensors shows that the most common form of icosahedral bacteriophage-based biosensors utilizes the spherical profile of the capsid as an alternative to conventional nanoparticles, onto which various peptides or protein subunits are expressed. [54] [55] [56] For example, Robertson et al 48 engineered a T4-based nanoprobe with applications in cellular imaging and flow cytometry by conjugating fluorescent dyes to the capsid. By inducing the expressing of NH 2 groups on the capsid for subsequent NH 2 -N-hydroxysuccinimide (NHS) conjugation with Alexa Fluor ® 546 (Life Technologies), the authors demonstrate cellular uptake of their proof-of-concept bacteriophage for a variety of imaging applications ( Figure 5A ). In another example, Barrett et al 57 conjugated or expressed a variety of structures -streptavidin, biotin, thiol groups, amine groups, and so on -onto the capsid of a T7 icosahedral bacteriophage. Others, such as Merril et al, 58 expressed protein on the capsid of a T4 bacteriophage for the targeting of specific biomolecules, nucleic acids, or protein biomarkers. In yet another example, Ren and Lai 59 expressed a peptide on the capsid of a T4 bacteriophage for the detection of a cancer antigen. There have also been slight modifications to such applications, as seen with Liu et al, 60 who engineered a T7-based bacteriophage for imaging applications by replacing the DNA within the bacteriophage with a fluorescent dye.
Another commonly utilized form of icosahedral bacteriophages used as a biosensor is the immobilization of bacteriophage onto a platform for the subsequent detection of bacteria via its tail fiber region. 61 For example, Arya et al 62 assembled
T4 bacteriophages onto an Au platform and demonstrated the ability to detect bacteria. Specifically, the Au platform is functionalized with dithiobis (succinimidyl propionate) for the covalent immobilization of the T4 bacteriophage via amine groups that were genetically introduced on the T4 capsid. Once the bacteriophages are bound to the Au platform, the tail fibers -orientated outwards -detect bacteria, all of which leads to a change in SPR signal ( Figure 5B ).
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In another example, Boss and Lieberman 63 developed a T4-based bacteriophage biosensor for the detection of bacteria by utilizing magnetic nanoparticles. Here, amine groups on magnetic nanoparticles form covalent bonds with alkylamine compounds genetically introduced on the T4 capsids, and the resulting modified bacteriophages are used with conventional sensors, such as SPR or QCM, as a means to improve their detection capacity. A slightly different approach was taken by Archer and Liu, 3 who removed the tail fibers of T4 bacteriophages to form capsid-only constructs. 64 After conjugating targeting moieties onto the capsids, the authors optimized the pH to reduce modified T4 aggregation upon their immobilization onto an amino-silanized sensor platform. Here, the authors demonstrated severe aggregation at pH 5.6 that decreases in degree as the pH shifts towards 8.8, at which point the modified bacteriophages are equally-distributed onto the sensor platform ( Figure 5C ). Ultimately, the authors validated the use of their modified bacteriophage with SPR or QCM systems as a means to improve conventional biosensor capabilities.
Recently, examples of multifunctional nanoprobes -engineered by conjugating nanoparticles onto the bacteriophage capsid -have emerged. For example, Edgar et al 65 conjugated quantum dots onto a T7 bacteriophage capsid for the detection of bacteria with a sensitivity of down to 10 cells/mL -1 . Here, the modified bacteriophages are generated by expressing biotinylated peptide on the capsid for subsequent binding to streptavidin-coated quantum dots ( Figure 5D ). Similarly, Caberoy et al 66 engineered a modified T7 bacteriophage for the detection of Tubby-like protein 1. Specifically, the authors expressed both 3C protease cleavage sites and biotinylation tags onto the capsid; upon selection of bacteriophages bound to streptavidin, the authors cleaved the 3C site to generate a biotinylated complementary DNA library.
Future opportunities for bacteriophages in biosensor applications
Viruses have been used in a variety of chemical and biological sensors, and new applications continue to emerge. 
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Nanoscale bacteriophage biosensors Bacteriophages, in particular, are one of the most successful viruses yet to have been applied towards biosensors, and can be grouped into the following three categories regardless of their filamentous or icosahedral classification: 1) specific peptides or proteins discovered through phage display technology are genetically-introduced onto the extraluminal surface of the bacteriophage for the detection of target analyte. In general, biosensors based on the use of nonlytic bacteriophages (ie, M13) form the majority of this class.
2) Specific bacterial cell markers are detected upon bacterial cell rupture via the use of a lytic phage, which infects the host, replicates its genome, and induces host cell lysis.
3) Bacteriophages act a nanoscaffolding material for the transportation of functional molecules or their immobilization in a variety of sensing devices.
The translation of bacteriophage-based biosensors from in vitro to in vivo settings must be preceded by toxicity examinations to eliminate any safety concerns. Furthermore, the sensitivity of the general public to genetically engineered bacteriophages must be taken into account, and this is arguably one of the largest hurdles in the field.
However, by coupling the aforementioned advantages of bacteriophages with the continued development of microand nanobased measurements and analytical devices, we predict a concurrent increase in safety awareness and subsequent improvements. Finally, it is important to note that the use of bacteriophages is not limited to the aforementioned categories. Bacteriophages with varying functions that express desired peptides or proteins on their surface can be engineered through the simple manipulation of the bacteriophage genome, and ultimately be used for the rapid and economical mass production of bacteriophage-based biosensors. Here, an appropriate understanding of the bacteriophage that covers a wide area of topics such as the structure and function of individual components and its life cycle must accompany such novel applications. In summary, we envision that the combination of such bacteriophages with analytical nanofabricated devices will emerge in novel applications as a powerful nanoscale tool for the detection of a wide spectrum of targets, ranging from biological agents (ie, proteins, bacteria, spores, viruses, toxins, and so on) to chemical agents or even explosives. Step 1
Step 2
Step 3 
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